Maxime Dely: How Long Can Europe Rely on U.S. Plasma
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post on LinkedIn:
”The core issue is clear: American Dependence: How long can Europe rely on U.S. Plasma?
In 2024, nearly 70 % of the world’s plasma used to produce plasma-derived medicinal products came from the United States. A figure that clearly shows how vulnerable Europe remains in a domain essential to patient care.
The U.S. collects around 50 million liters of plasma each year, enabled by a highly industrialized model, a dense network of donation centers, and financial compensation for donors.
By contrast, Europe collects only about 9 million liters, mostly concentrated in Austria, Germany, Hungary, and the Czech Republic. The rest of the continent remains largely dependent on imports.
Since 2023, global demand has been rising quickly (+ 12 to + 14%), driven by increased needs for immunoglobulins. But European collection is growing too slowly to close the gap.
To strengthen supply security, Europe has launched several initiatives:
โช๏ธ EU4Health and resilience programs,
โช๏ธ Investments to modernize collection infrastructures,
โช๏ธ Efforts to increase voluntary non-remunerated donations,
โช๏ธ Expansion of local fractionation capacity.
These initiatives represent real progress, but they come after years of structural dependence. Achieving European plasma sovereignty will require coordinated, long-term, and ambitious action.
The core issue is clear: ensuring continuous and secure access to plasma-derived medicines for all European patients.
In your review, what should be the top priority to rebalance this dependency?
Boosting collection? Rethinking the model? Investing in local production?”
Stay updated with Hemostasis Today.
-
Dec 15, 2025, 15:58Khaled Musallam Applauds Hatoon Ezzat’s Leadership and Healthcare Advances in Saudi Arabia
-
Dec 15, 2025, 12:46Deborah Ebert Long on Hemophilia Care: Progress, Possibility, and the Power of Listening
-
Dec 15, 2025, 12:34Nathan Connell on Conversion from Eptacog Alfa to Beta
-
Dec 15, 2025, 12:17Danny Hsu on Interdisciplinary Toolkit for Gynecologic Bleeding on Anticoagulation
-
Dec 15, 2025, 12:08Ted Roh: A Historic Milestone for Indonesiaโs Health Innovation
-
Dec 15, 2025, 11:28Wolfgang Miesbach Shares Insights from Davide Matino’s Presentation on Marstacimab at ASH25
-
Dec 15, 2025, 11:12Tushar Pandey Awarded for His Enourmous Contribution to Hematology
-
Dec 15, 2025, 11:07DISTRO: Vidya Rajbhoj on AI and Digital Technology to Improve Stroke Rehabilitation
-
Dec 15, 2025, 11:00Ischemic Stroke, AF and Atherosclerotis: Amira Khater on Sufficiency of Anticoagulant Monotherapy